Log in or Sign up for Free to view tailored content for your specialty!
Allergy/Asthma News
Vaccination delayed, avoided with dupilumab treatment
WASHINGTON — Children taking dupilumab for atopic diseases received measles, mumps and rubella and varicella immunizations later than other children, according to a poster presented here.
Asthma researcher wants moms, babies to breathe easier through pregnancy research
Vanessa Murphy, PhD, started her research career in a lab studying preterm birth, which is where she fell in love with pregnancy research.
Log in or Sign up for Free to view tailored content for your specialty!
Rebamipide may treat low-grade inflammation in post-COVID syndrome
WASHINGTON — Rebamipide has potential as treatment for low-grade inflammation among patients with post-COVID syndrome, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
US, world guidelines differ on when to use omalizumab in treating urticaria
WASHINGTON — Urticaria treatment guidelines in the United States include more options than the World Allergy Organization’s guidelines, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
Nemolizumab shows long-term efficacy in treatment of prurigo nodularis, atopic dermatitis
SAN DIEGO — At the American Academy of Dermatology Annual Meeting, Galderma announced new data demonstrating nemolizumab’s long-term efficacy in treating prurigo nodularis and atopic dermatitis, according to a press release.
Frequency of asthma, food allergy ED visits high in African American children
WASHINGTON — Compared with white, Asian and Hispanic children, African American children more frequently visited the ED because of asthma or a food allergy, according to study findings.
Pet owners with allergy can mitigate environmental exposures to allergens
WASHINGTON — Patients can keep their furry, four-legged friends and still control their pet allergy symptoms, according to a presentation at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
Omalizumab may benefit children with severe asthma, comorbid food allergy
Children with severe allergic asthma and serum total IgE levels between 1,500 kU/L and 3,300 kU/L as well as food allergy benefitted from omalizumab, according to a study published in Pediatric Allergy and Immunology.
BLOG: Rollover equity: Linking arms with your private equity partner
As we discussed in our overview of the private equity, or PE, physician practice model, the buyer in an acquisition is often a PE-sponsored management services organization that purchases the nonclinical aspects of the practice’s business.
Medium-dose inhaled corticosteroid plus LABA best for pediatric uncontrolled asthma
A medium inhaled corticosteroid dose plus a long-acting beta agonist was found to be the most beneficial step-up treatment option for children with uncontrolled asthma, according to a meta-analysis published in European Respiratory Journal.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read